First-of-its-kind Report Reveals Pediatric Brain Cancer Is Childhood Cancer Community's Biggest Crisis
Central Brain Tumor Registry of the United States' Statistical Report Validates Pediatric Brain Tumor Foundation's Urgent Call for Action to Reverse Brain Cancer Trends in Children and Adolescents
ATLANTA, Sept. 6, 2022 //PRNewswire// -- A new report published in Neuro-Oncology exposes an alarming reality for children, adolescents, and families facing pediatric brain cancer across the country. The Pediatric Brain Tumor Foundation (PBTF, curethekids.org) funded this first-of-its-kind report by the Central Brain Tumor Registry of the United States (CBTRUS, cbtrus.org) to increase understanding of the scope and severity of this childhood disease.
- More children under the age of 19 are diagnosed with brain tumors, and dying from them, than ever before, while adult brain cancer patients are experiencing a decline in the incidence of diagnosis and mortality rates.
- There are significant disparities in the incidence of diagnosis and mortality rates among states. While the report doesn't address the reasons for these disparities, we know that differences in access to treatment, environmental factors, and emphasis on pediatric cancer in state health policies warrant closer study.
- Pediatric brain cancer doesn't discriminate but is a disproportionate threat to children of color, who experience lower survival rates than white children.
- While mortality rates have increased, the need for attention to survivorship is greater than ever. The estimated number of children and adolescents in the United States living with the aftereffects of brain tumors has increased by 45% since 2010.
- Even as their odds for survival have declined, children and adolescents diagnosed with brain tumors are, on average, living longer. This increase brings a higher demand for health resources and palliative care education for patients, survivors, and their families.
"This report from CBTRUS validates what the Pediatric Brain Tumor Foundation has been saying for years: Pediatric cancer demands more attention and a greater investment in the development of new treatments and resources for patient families," says Courtney Davies, PBTF President and CEO. "Pediatric brain cancer trends are moving in the opposite direction of those for adults because childhood cancer does not receive the same level of attention, research, or financial commitment as adult cancers. The research community, pharmaceutical companies, healthcare policymakers, and funders must do more. Kids' lives are at stake."
There are more than 120 types of brain tumors in need of treatment advancements. Small patient populations for these individual tumor types, insufficient tissue samples, and the lack of research funding have led to an incomplete understanding of this disease.
Progress towards effective treatments or cures is also slow. Treatments developed for adult populations are ineffective for kids or contribute to long-term health complications. Because pediatric brain tumors are a numerically small problem, research scientists and pharmaceutical companies are not incentivized to study them. Meanwhile, the developmental, emotional, and financial impact on children diagnosed with brain tumors and their families is profound.
PBTF is committed to leading the way toward a future without childhood cancer. This report provides insights that are shaping our response to this public health crisis. As a result of our analysis of the report, we are:
- Focusing greater attention on state-level health policy and advocating for emphasis on pediatric health.
- Redoubling our commitment to funding promising early-stage research. Every dollar PBTF invests attracts 12 dollars in follow-on funding.
- Directing family support resources to states where the need is greatest and where each dollar can make the most difference.
There is no cure for pediatric cancer without collaboration, and we need patient advocacy organizations, pharmaceutical companies, researchers, and caring individuals to walk alongside us as we address the local impact of pediatric cancer. If you have questions about how you can make a difference, email us at [email protected]. Visit curethekids.org/cbtrus-report to view the full report.
No parent believes their child will be diagnosed with brain cancer. When it happens, no patient, parent, sibling, or survivor should have to stand alone. The Pediatric Brain Tumor Foundation is there for families facing the deadliest and most common childhood cancer, responding with resources and community support that address every family member's needs. The largest patient advocacy funder of pediatric brain tumor research, PBTF also funds and advocates for innovative projects that lead to vital discoveries, new clinical trials, and better treatments – all bringing us closer to a cure. We're able to do that because of people and partners committed to supporting families and ending childhood brain cancer. Learn more at curethekids.org.
SOURCE Pediatric Brain Tumor Foundation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article